2nd Quarter - Report

ASSOCIATION FOR ACCESSIBLE MEDICINES for ASSOCIATION FOR ACCESSIBLE MEDICINES

Firm
Client
Income
—
Expenses
$780,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

General Trade Issues. Trans-Pacific Partnership (TPP). Transatlantic Trade and Investment Partnership (TTIP). Biologic Exclusivity. USTR Confirmation. North American Free Trade Agreement.

LobbyistCovered position, as disclosed
JOHN BILLINGS New Chief of Staff/LD, Rep. Charles Bass; Chief of Staff, Dan Benishek; Policy Advisor, Rep. Mark Kirk
CHRISTOPHER BOWLIN —
MICHAEL BRZICA —
CHRISTIAN OMAR CRUZ —
JEFFREY FRANCER —
DAVID R. GAUGH —
ERIK C KOMENDANT —

Contacted: HOUSE OF REPRESENTATIVES; Government Accountability Office (GAO); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Office of Management & Budget (OMB); SENATE; U.S. Trade Representative (USTR); Centers For Medicare and Medicaid Services (CMS)

Taxation/Internal Revenue Code TAX

Taxation Issues Related to Opioid Pharmaceuticals. User Fee Programs.

LobbyistCovered position, as disclosed
JOHN BILLINGS New Chief of Staff/LD, Rep. Charles Bass; Chief of Staff, Dan Benishek; Policy Advisor, Rep. Mark Kirk
CHRISTOPHER BOWLIN —
MICHAEL BRZICA —
CRAIG BURTON New Dep. Assistant Sec. for Legislation, HHS; Staff, Senate HELP Committee; Staff, Senator Bill Frist
CHRISTIAN OMAR CRUZ —
CHESTER DAVIS —
JEFFREY FRANCER —
THOMAS JAMES GARRIGAN —
DAVID R. GAUGH —
ERIK C KOMENDANT —
HEIDI WILSON —

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Government Accountability Office (GAO); Office of Management & Budget (OMB); U.S. Trade Representative (USTR); SENATE; Centers For Medicare and Medicaid Services (CMS)

Copyright/Patent/Trademark CPT

Inter Partes Review (IPR) process. Patent Settlements.

LobbyistCovered position, as disclosed
JOHN BILLINGS New Chief of Staff/LD, Rep. Charles Bass; Chief of Staff, Dan Benishek; Policy Advisor, Rep. Mark Kirk
CHRISTOPHER BOWLIN —
MICHAEL BRZICA —
CHRISTIAN OMAR CRUZ —
JEFFREY FRANCER —
ERIK C KOMENDANT —
CHRISTINE SIMMON —

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); U.S. Trade Representative (USTR); Government Accountability Office (GAO); Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Medicare Part D Program and Generic Drugs. Medicare reimbursement for biosimilars. Medicaid Rebate Penalty. Medicare Part D Low Income Subsidy (LIS) Program.

LobbyistCovered position, as disclosed
JOHN BILLINGS New Chief of Staff/LD, Rep. Charles Bass; Chief of Staff, Dan Benishek; Policy Advisor, Rep. Mark Kirk
CHRISTOPHER BOWLIN —
MICHAEL BRZICA —
CRAIG BURTON New Dep. Assistant Sec. for Legislation, HHS; Staff, Senate HELP Committee; Staff, Senator Bill Frist
CHRISTIAN OMAR CRUZ —
CHESTER DAVIS —
THOMAS JAMES GARRIGAN —
DAVID R. GAUGH —
ERIK C KOMENDANT —
CHRISTINE SIMMON —
HEIDI WILSON —

Contacted: Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Government Accountability Office (GAO); SENATE; U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB)

Budget/Appropriations BUD

FDA Funding. S.2956: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017. H.R.5054: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017. S.Con.Res.3: A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026.

LobbyistCovered position, as disclosed
JOHN BILLINGS New Chief of Staff/LD, Rep. Charles Bass; Chief of Staff, Dan Benishek; Policy Advisor, Rep. Mark Kirk
CHRISTOPHER BOWLIN —
MICHAEL BRZICA —
CHRISTIAN OMAR CRUZ —
JEFFREY FRANCER —
THOMAS JAMES GARRIGAN —
DAVID R. GAUGH —
ERIK C KOMENDANT —
HEIDI WILSON —

Contacted: Office of Management & Budget (OMB); SENATE; Government Accountability Office (GAO); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR)

Bills named: H.R. 5054 (115th), S.Con.Res. 3 (115th), S. 2956 (115th)

Pharmacy PHA

Implementation of Food and Drug Administration Safety and Innovation Act (FDASIA) and Generic Drug User Fee Amendments (GDUFA). Biosimilar User Fee Act (BsUFA). Labeling of Generic Drugs. Biosimilars Naming. Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products. Prescription Drug Costs. H.R.2841: FAST Generics Act of 2015. H.R.2051: FAST Generics Act of 2017. S.124: Preserve Access to Affordable Generics Act. H.R.1245/S.469: Affordable and Safe Prescription Drug Importation Act. H.R.1314: Bipartisan Budget Act of 2015. Risk Evaluation and Mitigation Strategies (REMS). Biologic Exclusivity. Biologics Price Competition and Innovation Act (BPCIA). H.R.2562/S.1115: Making Pharmaceutical Markets More Competitive Act. S.771: Improving Access To Affordable Prescription Drugs Act. Pharmaceutical Exclusivity. S.3056: CREATES Act of 2016. H.R.2212/S.974: CREATES Act of 2017. H.R.6043/S.3335: Fair Accountability and Innovative Research Drug Pricing Act of 2016. S.297: Increasing Competition in Pharmaceuticals Act. H.R.749: Lower Drug Costs through Competition Act. Drug Importation. H.R.2430/S.934: FDA Reauthorization Act of 2017. FDA Commissioner Nomination.

LobbyistCovered position, as disclosed
JOHN BILLINGS New Chief of Staff/LD, Rep. Charles Bass; Chief of Staff, Dan Benishek; Policy Advisor, Rep. Mark Kirk
CHRISTOPHER BOWLIN —
MICHAEL BRZICA —
CRAIG BURTON New Dep. Assistant Sec. for Legislation, HHS; Staff, Senate HELP Committee; Staff, Senator Bill Frist
CHRISTIAN OMAR CRUZ —
CHESTER DAVIS —
JEFFREY FRANCER —
THOMAS JAMES GARRIGAN —
DAVID R. GAUGH —
ERIK C KOMENDANT —
CHRISTINE SIMMON —
HEIDI WILSON —

Contacted: Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); SENATE; Government Accountability Office (GAO); Centers For Medicare and Medicaid Services (CMS); Office of Management & Budget (OMB)

Bills named: H.R. 749 (115th), H.R. 2212 (115th), H.R. 1314 (115th), H.R. 1245 (115th), S. 974 (115th), H.R. 6043 (115th), S. 3335 (115th), H.R. 2562 (115th), S. 934 (115th), S. 469 (115th), S. 297 (115th), S. 3056 (115th), S. 124 (115th), S. 1115 (115th), S. 771 (115th), H.R. 2430 (115th), H.R. 2841 (115th), H.R. 2051 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.